Fritextsökning
Innehållstyper
-
Biovica flyttar över Atlanten
Öppnar sitt första kontor i USA.
-
Unga forskare prisas
Upptäckt koppling mellan tarmfloran och fetma belönas när pris för unga forskare delas ut i Stockholm.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
-
Första resultaten för nygammalt läkemedel mot covid-19
I en ny studie förbättrades tillståndet för 68 procent av patienter med allvarlig covid-19 när de fick läkemedlet remdesivir. Men studien har flera svagheter oc...
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Rosling ger namn åt nytt folkhälsocenter i USA
Roslings föreläsningar och TED talks har upplyst miljontals människor om folkhälsan i världen. Nu hedras hans minne med ett nytt folkhälsocenter på University o...
-
Pengar och support på önskelistan
I senaste Scanbaltrapporten identifierar organisationen fem huvudområden för att förbättra förutsättningarna inom life scienceindustrin i länderna kringa Baltik...
-
Ny chef på Puls
Rekryterar chef från danska Leo Pharma.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Smart "trial and error" för snabbare innovation
För att bli och förbli konkurrenskraftiga måste dagens företag och organisationer innovera i allt snabbare takt.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Han tar över på Apotekstjänst
Ny vd ska lösa logistikproblematiken
-
Svensk innovation minskar risken för hjärnskador
Ett flertal oberoende tester av hjälmar för olika fritidsaktiviteter har en sak gemensamt. De modeller som ligger i topp är oftast utrustade med MIPS-teknik, en...
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
BREAKING